Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt repayments

Daily Values

Growth Metrics

Others

Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Receivables - Net Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased Short-Term Debt repayments

Hims & Hers Health (HIMS) Preferred Shares Issued (2020)

Hims & Hers Health (HIMS) has disclosed Preferred Shares Issued for 1 consecutive years, with -$27000.0 as the latest value for Q4 2020.

Quarterly Preferred Shares Issued changed N/A to -$27000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was -$27000.0 through Sep 2021, changed N/A year-over-year, with the annual reading at $51.9 million for FY2020, 49.4% down from the prior year.
Preferred Shares Issued hit -$27000.0 in Q4 2020 for Hims & Hers Health, down from $14.4 million in the prior quarter.
In the past five years, Preferred Shares Issued ranged from a high of $31.6 million in Q1 2020 to a low of -$27000.0 in Q4 2020.